Litcius/Paper detail

Stimuli-Responsive Gene Delivery Nanocarriers for Cancer Therapy

Qingfei Zhang, Gaizhen Kuang, Wenzhao Li, Jinglin Wang, Haozhen Ren, Yuanjin Zhao

2023Nano-Micro Letters151 citationsDOIOpen Access PDF

Abstract

Gene therapy provides a promising approach in treating cancers with high efficacy and selectivity and few adverse effects. Currently, the development of functional vectors with safety and effectiveness is the intense focus for improving the delivery of nucleic acid drugs for gene therapy. For this purpose, stimuli-responsive nanocarriers displayed strong potential in improving the overall efficiencies of gene therapy and reducing adverse effects via effective protection, prolonged blood circulation, specific tumor accumulation, and controlled release profile of nucleic acid drugs. Besides, synergistic therapy could be achieved when combined with other therapeutic regimens. This review summarizes recent advances in various stimuli-responsive nanocarriers for gene delivery. Particularly, the nanocarriers responding to endogenous stimuli including pH, reactive oxygen species, glutathione, and enzyme, etc., and exogenous stimuli including light, thermo, ultrasound, magnetic field, etc., are introduced. Finally, the future challenges and prospects of stimuli-responsive gene delivery nanocarriers toward potential clinical translation are well discussed. The major objective of this review is to present the biomedical potential of stimuli-responsive gene delivery nanocarriers for cancer therapy and provide guidance for developing novel nanoplatforms that are clinically applicable.

Topics & Concepts

NanocarriersGenetic enhancementCancer therapyGene deliveryCancerMedicineGeneBiologyPharmacologyInternal medicineGeneticsDrugRNA Interference and Gene DeliveryNanoplatforms for cancer theranosticsGraphene and Nanomaterials Applications
Stimuli-Responsive Gene Delivery Nanocarriers for Cancer Therapy | Litcius